Thus, perilipin-2 expression and lipid droplet formation appear to be involved in podocyte injury occurring in primary FSGS, and could potentially serve as biomarkers for the presence of CPF(s) in plasma from FSGS patients. The gene discussed is PLIN2; the disease is focal segmental glomerulosclerosis.